Q3 2025 Earnings Forecast for Bruker Co. Issued By Zacks Research (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKR) – Equities research analysts at Zacks Research decreased their Q3 2025 earnings per share estimates for Bruker in a note issued to investors on Wednesday, September 18th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $0.94 per share for the quarter, down from their previous estimate of $0.96. The consensus estimate for Bruker’s current full-year earnings is $2.61 per share.

Several other analysts have also issued reports on BRKR. TD Cowen dropped their price objective on Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research note on Wednesday, August 7th. The Goldman Sachs Group cut their price target on Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, July 9th. Citigroup decreased their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. Wells Fargo & Company assumed coverage on shares of Bruker in a research note on Tuesday, August 27th. They set an “overweight” rating and a $78.00 target price for the company. Finally, Jefferies Financial Group initiated coverage on shares of Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.40.

Bruker Stock Down 1.1 %

Shares of BRKR stock opened at $67.54 on Monday. Bruker has a 52-week low of $53.79 and a 52-week high of $94.86. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.75 and a current ratio of 1.65. The stock has a market cap of $9.82 billion, a price-to-earnings ratio of 24.56, a PEG ratio of 2.31 and a beta of 1.18. The firm’s 50-day moving average is $64.56 and its 200-day moving average is $72.64.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.52. The company had revenue of $800.70 million for the quarter, compared to analysts’ expectations of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business’s revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.50 EPS.

Institutional Investors Weigh In On Bruker

Hedge funds and other institutional investors have recently made changes to their positions in the business. Rise Advisors LLC bought a new position in Bruker during the 1st quarter worth $27,000. Covestor Ltd raised its stake in Bruker by 139.1% in the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock valued at $34,000 after purchasing an additional 210 shares in the last quarter. First Horizon Advisors Inc. lifted its position in Bruker by 120.4% during the second quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock worth $25,000 after purchasing an additional 218 shares during the period. Neo Ivy Capital Management acquired a new stake in Bruker during the fourth quarter worth about $30,000. Finally, Principal Securities Inc. bought a new position in Bruker in the 4th quarter valued at about $42,000. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Monday, September 2nd were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 annualized dividend and a dividend yield of 0.30%. Bruker’s dividend payout ratio is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.